Konstantina Psachoulia

Author

AstraZeneca (United States)

Also Known As

K. Psachoulia, Konstantina Psachoulia, Psachoulia, K

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)University College London AstraZeneca (Sweden)AstraZeneca (United Kingdom)

About

Konstantina Psachoulia is an author at AstraZeneca (United States) specializing in medicine, neuroscience, and neuroanatomy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	2.1K
2	Social Sciences	3	3	2K
3	Cell Biology	1	1	252
4	Cellular Physiology	1	1	252
5	Immunology	1	1	34

Konstantina Psachoulia

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice Leanne E. Rivers, Kaylene M. Young, Matteo Rizzi, Nature Neuroscience Glial BiologyProjection NeuronsMolecular NeuroscienceDevelopmental BiologyNeuroanatomy	2008	932
Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling Kaylene M. Young, Konstantina Psachoulia, Richa B. Tripathi, Neuron NeuroregenerationNeurophysiologyNeuroanatomyOligodendrocyte DynamicsPhysiology	2013	849
Cell cycle dynamics of NG2 cells in the postnatal and ageing brain Konstantina Psachoulia, Françoise Jamen, Kaylene M. Young, Neuron Glia Biology Brain DevelopmentCell Cycle DynamicsCell CycleCumulative Brdu LabellingNg2 Cells	2009	252
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation Konstantina Psachoulia, Kelly A. Chamberlain, Dongeun Heo, Brain	2016	99
LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults Myron J. Levin, Andrew Ustianowski, Stéphane De Wit, Open Forum Infectious Diseases ImmunodeficienciesImmunologyImmunodominanceCovid-19 EpidemiologyAntiviral Drug	2021	34
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials Ian N Bruce, Ronald van Vollenhoven, Konstantina Psachoulia, Lupus Science & Medicine	2023	27
Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD Hiddo J.L. Heerspink, Gordon Law, Konstantina Psachoulia, Kidney International Reports	2021	11

Page 1